EPHB6
Overview
EPHB3 is a member of the Eph receptor family, which are a group of receptor tyrosine kinases that play a crucial role in developmental processes, particularly in the nervous system and in the formation of the vascular system. EPHB3 is encoded by the EPHB3 gene in humans.
Structure
EPHB3, like other Eph receptors, consists of an extracellular region, a single transmembrane segment, and a cytoplasmic tyrosine kinase domain. The extracellular region contains a ligand-binding domain, a cysteine-rich region, and two fibronectin type III repeats. The intracellular region is responsible for signal transduction.
Function
EPHB3 is involved in various cellular processes, including cell adhesion, cell migration, and cell positioning. It interacts with ephrin-B ligands, which are membrane-bound proteins, to initiate bidirectional signaling. This signaling is crucial for:
- Axon guidance during neural development.
- Angiogenesis, the formation of new blood vessels.
- Tissue boundary formation and maintenance.
Signaling Pathway
EPHB3 signaling involves both forward and reverse signaling. Forward signaling occurs when EPHB3 binds to its ephrin-B ligands, leading to autophosphorylation and activation of downstream signaling pathways. Reverse signaling occurs in the ephrin-expressing cell, influencing its behavior and function.
Clinical Significance
Alterations in EPHB3 expression and function have been implicated in various diseases, including:
- Cancer: EPHB3 has been shown to play a role in tumor progression and metastasis.
- Neurodevelopmental disorders: Abnormal EPHB3 signaling can affect brain development and function.
Research
Ongoing research is focused on understanding the precise mechanisms of EPHB3 signaling and its role in disease. Targeting EPHB3 and its pathways is being explored as a potential therapeutic strategy in cancer and other diseases.
Also see
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD